Ovarian Cancer: 172 Real Stories

172 stories match ovarian cancer. 150 of them mention surgery.

Kimberly, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Kimberly's Survivor Story

Patient Info: Kimberly Richardson, 50s

Kimberly described living with no evidence of disease while undergoing frequent tumor-marker surveillance because granulosa cell tumors can recur.

AACR
OutcomeCancer-Free / NED
Stacy, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Stacy's Patient Story

Patient Info: Stacy Saravo, female

After treatment, Stacy was active in survivorship, peer support, patient education, hiking, and scent-work activities with her dog.

Ovarian Cancer Research Alliance
OutcomeNot reported
Jamie, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Jamie's Patient Story

Patient Info: Jamie, female, Under 40

By age 28, Jamie was rebuilding physical strength after two surgeries and had trained as an OCRA peer mentor.

Ovarian Cancer Research Alliance
OutcomeNot reported
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Wilms tumor arising in a mature cystic teratoma

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; PAX8-positive

After the diagnosis was revised to ovarian Wilms tumor, she was advised to see a gynecologic oncologist but did not return for follow-up.

PubMed Central
OutcomeNot reported
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Wilms tumor with early abdominal recurrence

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; residual tumor MyoD1-positive

After 3 months of radiation and a further 3 months of chemotherapy, PET showed no FDG-avid malignancy.

PubMed Central
OutcomeCancer-Free / NED
OC
Ovarian Cancer

Ovarian cancer that later spread to an axillary lymph node

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: axillary lymph nodes

After later peritoneal progression, additional treatment brought the disease to a stable state through her last recorded visit in July 2019.

PubMed Central
OutcomeStable Disease
OC
Ovarian Cancer

Ovarian cancer presenting with axillary lymph-node spread

Patient Info: Anonymized, Female, Under 40 | Stage IV

Metastatic Site: axillary lymph nodes

A 39-year-old woman with high-grade serous ovarian cancer had confirmed spread to an axillary lymph node at diagnosis and underwent extensive cytoreductive surgery.

PubMed Central
OutcomeNot reported
SI
Ovarian Cancer

Stage IV ovarian cancer with axillary lymph-node spread

Patient Info: Anonymized, Female, 50s | Stage IV

Metastatic Site: axillary lymph nodes

A 58-year-old woman with ovarian serous carcinoma and axillary lymph-node spread received chemotherapy, cytoreductive surgery, and postoperative chemotherapy.

PubMed Central
OutcomeNot reported
Patty, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage III BRCA1 Ovarian Cancer: Patty's Patient Story

Patient Info: Patty Klein, Female | Stage III

Biomarkers: BRCA1 mutation

Patty was able to continue the olaparib plus BKM120 clinical trial as long as her tumor remained controlled. She later died.

AACR
OutcomeIn Memory
Mary, who was diagnosed with Stage I Ovarian CancerOvarian Cancer

Stage I Ovarian Cancer: Mary's Survivor Story

Patient Info: Mary “Dicey” Jackson Scroggins, 40s | Stage I

Nearly 2 decades after treatment, Dicey remained free of ovarian-cancer recurrence.

AACR
OutcomeCancer-Free / NED
Angela, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage III Ovarian Cancer: Angela's Survivor Story

Patient Info: Angela Hernandez, female | Stage III

After completing chemotherapy, follow-up appointments continued to confirm that she was cancer-free.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Stable Brain Metastases During Niraparib Maintenance for Ovarian Cancer

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: CA-125 4019 kU/L; pathogenic germline BRCA1 mutation

Metastatic Site: brain

After 17 months of niraparib, her brain metastases remained stable. She had a performance status of 0 and reported a full, normal quality of life.

PubMed Central
OutcomeStable Disease
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer Relapse Causing Fluid Around the Heart

Patient Info: Anonymized, Female, 50s | Stage Metastatic/Advanced

Biomarkers: PAX8 positive; CK7 positive; WT1 positive; p53 positive; ER positive; PR negative; isolated PMS2 loss; MSH2 retained; MSH6 retained; MLH1 retained; two BRCA1 variants of uncertain significance

Metastatic Site: omentum|pericardium

She was alive after completing chemotherapy for the pericardial relapse and was receiving olaparib maintenance. The fluid around the heart did not recur immediately after the surgical window.

PubMed Central
OutcomeCare Ongoing
Tabby, who was diagnosed with Small Cell Lung CancerOvarian Cancer

Small Cell Lung Cancer: Tabby's Survivor Story

Patient Info: Tabby Soignier, female, Under 40

A December 2011 CT scan and lab work showed Tabby was cancer-free; she continued regular follow-up and later conceived naturally and gave birth to a healthy son.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Ovarian AdenocarcinomaOvarian Cancer

Stage IV Ovarian Cancer With Severe Recurrent Ascites

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: peritoneum|liver

The cancer progressed with massive ascites, liver involvement, and respiratory failure. She died from multiorgan failure related to metastatic ovarian cancer.

PubMed Central
OutcomeIn Memory
Dena, who was diagnosed with Ovarian CancerOvarian Cancer

BRCA Ovarian Cancer: Dena's Patient Story

Patient Info: Dena Svoboda, Female, 50s

Biomarkers: BRCA mutation

Nearly 4 years after surgery and heated intraperitoneal chemotherapy, Dena’s cancer had not recurred, and she continued intravenous chemotherapy every 5 weeks with minimal side effects.

Cleveland Clinic
OutcomeResponding Well
AO
Ovarian Cancer

Advanced Ovarian Cancer Presenting With Dermatomyositis

Patient Info: Anonymized, Female, 50s

Biomarkers: CA-125 3169 at diagnosis; later CA-125 rise with progression

After a partial response to second-line chemotherapy, nodal disease progressed again 5 months later and liposomal doxorubicin was planned.

PubMed Central
OutcomeSetback / Progression
OC
Ovarian Cancer

Ovarian Cancer With Pleural Spread and Recurrent Dermatomyositis

Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced

Metastatic Site: pleura

She had symptomatic improvement after 2 cycles of carboplatin and liposomal doxorubicin for recurrent disease.

PubMed Central
OutcomeResponding Well
Janelle, who was diagnosed with Stage IV Ovarian CancerOvarian Cancer

Stage IV Ovarian Cancer: Janelle's Patient Story

Patient Info: Janelle Kister, female | Stage IV

Treatment ended, and Janelle was still doing well 17 years after her Stage IV ovarian cancer diagnosis.

MD Anderson
OutcomeNot reported
A patient, who was diagnosed with Stage IV Ovarian CancerOvarian Cancer

Stage IV ovarian cancer presenting as a persistent umbilical ulcer

Patient Info: Anonymized, Female, 40s | Stage IV

Metastatic Site: bilateral cardiophrenic lymph nodes

She recovered from extensive cytoreductive surgery without major abdominal or pulmonary complications and began adjuvant paclitaxel and carboplatin on postoperative day 25.

PubMed Central
OutcomeCare Ongoing
SI
Ovarian Cancer

Stage IV Ovarian Cancer With 20 Years of Tumor-Free Survival

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: BRCA1 negative, BRCA2 negative

Metastatic Site: peritoneum, liver, right adrenal gland

Regular follow-up found no recurrence or other tumor, and at 20 years of follow-up she remained tumor-free with good health and quality of life.

PubMed Central
OutcomeCancer-Free / NED
Leslie, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Leslie's Patient Story

Patient Info: Leslie Medley-Russell, female

She was receiving chemotherapy for a second ovarian cancer diagnosis while continuing to train and compete in endurance events.

MD Anderson
OutcomeCare Ongoing